Back to top

Image: Bigstock

Why Acerinox (ANIOY) Might Be a Diamond in the Rough

Read MoreHide Full Article

It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out. Before they take the plunge, others get to know the hidden potential and enter into these stocks, pushing them out of reach.

So, instead of repenting, spotting the off-the-radar potential winners and immediately investing in them could be a smart decision.

One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Acerinox S.A. (ANIOY - Free Report) . This Steel - Producers industry stock has actually seen estimates rise over the past month for the current fiscal year by about 28.3%. But that is not yet reflected in its price, as the stock lost 3.2% over the same time frame.

ACERINOX SA ADR Price and Consensus

ACERINOX SA ADR Price and Consensus | ACERINOX SA ADR Quote

You should not be concerned about the price remaining muted going forward. This year’s expected earnings growth over the prior year is over 100%, which should ultimately translate into price appreciation.

And if this isn’t enough, Acerinox currently carries a Zacks Rank #2 (Buy) which further underscores the potential for its outperformance (See the performance of Zacks' portfolios and strategies here: About Zacks Performance).You can see the complete list of today’s Zacks #1 Rank stocks here.

So if you are looking for a stock flying under-the-radar that is well-equipped to bounce down the road, make sure to consider Acerinox. Solid estimate revisions and an impressive Zacks Rank suggest that better days may be ahead for ANIOY and that now might be an interesting buying opportunity.

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Acerinox (ANIOY) - free report >>

Published in